Calendar

«« Feb 2008 »»
S M T W T F S
         
1
2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29

Search Box


HealthCentral Top Site Award

IBS Tales Hope Award

LinkBlog

[USA] Think Social Networks, Blogs Can’t Hurt You? Health insurers can use your on-line posts to avoid paying for treatment

Debunking the 'Chemical Imbalance' myth (pdf)

The Johns Hopkins Guide to Antidepressants (Note: requires registration of a valid email address)

Not Depressed, Just British!

  More

Contact

Mailing List

RSS Feeds








Translation

Disclaimer

All content within Anxiety Insights is provided for general information only, and should not be treated as a substitute for the medical advice of your doctor or other health care professional.

Anxiety Insights is not responsible or liable for any diagnosis made by a reader based on the content of this website.

Anxiety Insights is not liable for the contents of any external internet sites listed, nor does it endorse any commercial product or service mentioned or advised on any of the sites.

Always consult your doctor if you are in any way concerned about your health.

recommended links

Depression is Real's Down & Up Show
      Weekly audio-casts from the
      Depression Is Real Coalition

we support

Kiva.org - micro loans that change lives

Moving a Nation to Care : Post Traumatic Stress Disorder and America's Returning Troops, by Ilona Meagher

No Longer Lonely.com

"just don't smoke"


"Don't smoke, whatever you do, just don't smoke."
                        Yul Brynner

Hit Counter

Total: 1,194,396
since: 14 May 2006

Admin console

Log-In

My Blog    My Profile

Leave Message

Add as neighbors






Blogion.com

Blog Flux Directory



Blogarama - The Blogs Directory

blog search directory

BlogTagstic - Blog Directory

Find Blogs in the Blog Directory



LS Blogs

Top Health Sites





Health Blogs - Blog Top Sites

Webloogle Blog Directory

Bloggapedia - Find It!

Latest tagged entries for 'GAD'


next »

Salivary cortisol levels may be a biomarker for late-life GAD

Wednesday, 7 March 2007 5:19 A GMT+01
Salivary cortisol levels, a measure of hypothalamic-pituitary-adrenal (HPA) function, may be a biomarker of disease and treatment response in late-life generalized anxiety disorder (GAD),

Cymbalta® gets FDA approval for Generalized Anxiety Disorder

Tuesday, 27 February 2007 6:46 A GMT+01
Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved its antidepressant Cymbalta® (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD). The safety and efficacy of Cymbalta was estab

Cochrane Review confirms effectiveness of CBT for Generalized Anxiety Disorder

Wednesday, 24 January 2007 8:01 A GMT+01
The review showed that psychological therapy using a cognitive behavioral therapy approach is effective for GAD.

Are children with separation anxiety heading for panic disorder as adults?

Wednesday, 3 January 2007 5:12 A GMT+01
There has been extensive discussion on the relationship between separation anxiety in children and subsequent onset of panic disorder in adulthood.

Late-onset GAD more common than thought

Thursday, 21 December 2006 6:15 A GMT+01
Generalized anxiety disorder occurs as a late-onset condition more often than is recognized, according to investigators who presented the first large treatment trial in elderly patients

Abstract: Prevalence of GAD in Denmark, Finland, Norway, and Sweden

Saturday, 9 December 2006 5:33 A GMT+01
This study assessed the prevalence rate of generalized anxiety disorder among patients of general practitioners in Denmark, Finland, Norway, and Sweden and determined whether general practitioners recognize the condition and its correlates.

'Katrina Brain' pervasive after hurricane

Thursday, 23 November 2006 8:06 A GMT+01
In the aftermath of hurricane Katrina, patients here suffered from a generalized anxiety disorder dubbed "Katrina Brain," a psychiatrist reported here.

[U.S.A] UCLA seeks candidates with GAD for rTMS trial

Friday, 3 November 2006 7:41 A GMT+01
The Anxiety Disorders Program at the Semel Institute at UCLA is seeking candidates for a research trial to treat Generalized Anxiety Disorder (GAD) with repetitive transcranial magnetic stimulation (rTMS). GAD is characterized by excessive and uncont

Antipsychotic deemed effective for anxiety disorder

Saturday, 28 October 2006 7:45 A GMT+01
The anti-psychotic drug trifluoperazine is well-tolerated and superior to inactive "placebo" in the short-term treatment of generalized anxiety disorder, a chronic disorder associated with exaggerated worry and tension,

It's a Brain Thing

Friday, 20 October 2006 5:54 A GMT+01
'It's a Brain Thing' is a lecture series by psychiatrist David Henley, M.D. aimed at reducing the stigma and discrimination of mental disorders through attempting to understand the science of the brain and viewing them as illnesses of that organ.

Abstract: Comorbid GAD may delay depressed elderly mortality

Thursday, 12 October 2006 7:37 A GMT+01
Int J Geriatr Psychiatry. 2006 Sep 22; The relationship between generalized anxiety disorder, depression and mortality in old age. Holwerda TJ, Schoevers RA, Dekker J, Deeg DJ, Jonker C, Beekman AT. Department of Psychiatry,

Misdiagnosing Narcissism - Generalized Anxiety Disorder (GAD)

Friday, 29 September 2006 6:18 A GMT+01
Anxiety Disorders - and especially Generalised Anxiety Disorder (GAD) - are often misdiagnosed as Narcissistic Personality Disorder (NPD).

EPIX's GAD drug fails pivotal trial

Friday, 22 September 2006 7:19 A GMT+01
EPIX Pharmaceuticals has announced that the top-line results from its Phase 3 trial of PRX-00023, a novel long-acting 5-HT1A agonist, show that overall the drug did not achieve a statistically significant improvement over placebo for the primary end

Pregabalin effective and safe for GAD in elderly

Wednesday, 20 September 2006 8:59 A GMT+01
Pregabalin is efficacious in relieving symptoms of generalised anxiety disorder (GAD) in patients aged 65 years or older, according to an 8-week, multicentre, randomised, flexible-dose, placebo-controlled, double-blind, parallel-group, phase 3 trial

GAD diagnosis criteria should not be limited to 6-month duration

Wednesday, 16 August 2006 7:01 A GMT+01
Study findings have refuted the clinical significance of the 6-month duration criterion for generalized anxiety disorder.

Abstract: Study confirms GAD familial link

Friday, 11 August 2006 9:19 A GMT+01
Psychol Med. 2006 Sep;36(9):1275-81. A population-based family study of DSM-III generalized anxiety disorder. Newman SC, Bland RC. Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada.

Abstract: Placebo more effective than Kava in 3 GAD trials

Friday, 4 August 2006 6:40 A GMT+01
Int Clin Psychopharmacol. 2006 Sep;21(5):249-53. Kava in generalized anxiety disorder: three placebo-controlled trials.

Abstract: Pregabalin in the treatment of generalised anxiety disorder

Saturday, 29 July 2006 7:03 A GMT+01
Pregabalin, the pharmacologically active S-enantiomer of 3-aminomethyl-5-methyl-hexanoic acid, is a structural analogue of GABA, although it is not active at GABA receptors, nor does it acutely alter GABA uptake or degradation.

Abstract: Azapirones for generalized anxiety disorder

Sunday, 23 July 2006 8:47 A GMT+01
Azapirones are a group of drugs that work at the 5-HT1A receptor and are used to treat patients suffering from generalized anxiety disorder (GAD). However, several studies have shown conflicting results.

Abstract: Efficacy and safety of pregabalin in the treatment of GAD

Thursday, 20 July 2006 7:18 A GMT+01
J Clin Psychiatry. 2006 May;67(5):771-82 Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.

Gabitril® (tiagabine) fails GAD trial

Tuesday, 27 June 2006 6:19 A GMT+01
Cephalon, Inc. announced today that data from the Phase III clinical program evaluating its epilepsy drug Gabitril® (tiagabine hydrochloride) for the treatment of generalized anxiety disorder (GAD) did not reach statistical significance

Pregabalin shows all-round GAD treatment potential

Thursday, 15 June 2006 4:58 A GMT+01
Pregabalin appears to be effective for the treatment of generalized anxiety disorder (GAD), providing relief from the physical-somatic as well as emotional symptoms of the condition, study findings show.

Predix anti-anxiety drug gets positive Phase II trial results

Wednesday, 14 June 2006 7:12 A GMT+01
Predix Pharmaceuticals announced today that a Phase II clinical trial of its lead drug candidate, PRX-00023, showed significantly reduced symptoms and was well-tolerated in the 21 patients with generalized anxiety disorder (GAD)

Phase II/III trial of MN-305 shows promise as GAD treatment

Monday, 12 June 2006 6:21 A GMT+01
MediciNova, Inc., has announced the results of its Phase II/III randomized, double-blind, placebo-controlled clinical trial of MN-305 in 416 patients with Generalized Anxiety Disorder (GAD). Trends for improvement in all efficacy outcome measures wer

Compulsive hoarding found common in GAD and Social Phobia

Tuesday, 23 May 2006 6:16 A GMT+01
MIAMI - Compulsive hoarding is manifest in more than just a subset of patients with obsessive-compulsive disorder. A percentage of patients with general anxiety disorder and social phobia also reported hoarding symptoms in a study presented at the an

next »